MAXCYTE, INC.
MXCTCIK 0001287098 · Services-Commercial Physical & Biological Research · Nasdaq
- MAXCYTE INC (until 2008-09-18)
Revenue (TTM)
$20.67M
−5.7% YoY
Q1 May 2026
Net Income (TTM)
−$39.78M
−8.7% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.38
−7.7% YoY
Q1 May 2026
Gross Margin
141.2%
Q1 May 2026
Operating Margin
-226.7%
Q1 May 2026
Net Margin
-192.5%
Q1 May 2026
Free Cash Flow (TTM)
−$40.56M
Q1 May 2026
Cash
$14.56M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
107.12M sh
Q1 May 2026